Outer membrane vesicle antigen (OMV antigen)

Outer membrane vesicles (OMVs) are small, spherical, bilayered vesicles (typically 20–300 nm in diameter) naturally released by Gram-negative bacteria as a result of outer membrane budding. OMVs consist of outer membrane and periplasmic components, carrying bacterial proteins (including virulence factors and antigens), lipids, polysaccharides (notably lipopolysaccharide), nucleic acids, and other molecules. OMVs play critical roles in bacterial pathogenesis, including delivery of toxins and virulence factors to host cells, modulation of immune responses (either activating or evading immune detection), formation of biofilms, antibiotic resistance dissemination, and horizontal gene transfer. Due to their intrinsic immunogenicity and the ability to be engineered to display heterologous antigens, OMVs have been developed as vaccine platforms, most notably in licensed vaccines for Neisseria meningitidis serogroup B, and are the subject of ongoing research for infectious disease and cancer vaccination. However, "outer membrane vesicle antigen" is not the name of a specific molecular target or antigenic species, but rather refers generically to any antigenic components contained within or presented on OMVs. Thus, this term does not refer to a canonical, unique molecule or targetable receptor and is ambiguous in molecular targeting contexts. The phrase "outer membrane vesicle antigen" is not standard nomenclature for a specific, defined molecular entity; it is a generic designation for the antigenic components associated with bacterial OMVs and does not denote a unique protein, receptor, enzyme, or similar molecular target. For vaccine design and immunotherapy, individual antigens from OMVs are specifically identified and characterized, but are not named "outer membrane vesicle antigen" per se; the immunogenic proteins or polysaccharides are referenced directly by their unique names. The entry "outer membrane vesicle antigen" is ambiguous and not a true molecular target, but refers generically to mixed bacterial antigens present in OMVs; it is not suitable for use as a canonical molecular target in structured data systems.

Other names

Outer membrane vesicleOMVbacterial OMVouter membrane vesicle antigen (ambiguous/informal synonym)

Vaccine antigen delivery; Adjuvanticity (immune stimulation) as vaccine component